Terpenoid Therapeutics, Inc. is an entrepreneurial drug discovery and development company focused on anti-cancer therapeutics. We use the platform of terpene chemistry to develop candidate drug molecules. Our team is creating, testing, and developing novel drug candidates using cutting-edge technologies. We seek to generate a robust pipeline of terpene-derived therapeutic agents.
-
Terpenoid's bisphosphonate project is based on proprietary terpenoid-modified bisphosphonate inhibitors of geranylgeranyl diphosphate synthase (GGDPS), a novel target for which there are currently no approved drugs. Terpenoid predicts that inhibition of GGDPS will result in efficacy in the treatment of primary tumors and metastases (including, but not limited to, bone metastases).
-
Terpenoid's schweinfurthin project is focused on discovering and developing a drug with activity against primary tumors and metastases. This project is based on rare schweinfurthin natural products whose unique profile of anti-cancer activity was first reported by the National Cancer Institute in 1998.
-
March 20, 2011
Terpenoid Therapeutics secures nearly $450,000 in new grant support
Terpenoid Therapeutics Inc., a University of Iowa spinout company based in Coralville, Iowa, has secured nearly $450,000 in new grant support from the National Institutes of Health (NIH) and tax credits from the Internal Revenue Service.
more... -
February 21, 2011
Terpenoid Therapeutics, Inc named a Prometheus Award Finalist
Finalists for the 2011 Prometheus Awards have been announced by the Technology Association of Iowa (TAI), and Terpenoid Therapeutics, Inc (TTI) has been selected as a finalist in the Life Sciences Company of the Year category. Winners will be announced at a ceremony in Altoona, Iowa on April 7th.
more... -
August 31, 2010
Openings for Chemist and Biology Positions
Terpenoid Therapeutics Inc. is now filling open positions for a Biology Research Assistant and a Chemistry Research Assistant. Terpenoid Therapeutics, based in Coralville, IA, is an ambitious early stage biotechnology company focused on the development of therapeutics for cancer and osteoporosis.
more...